These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32155909)

  • 1. A Review of the Potential Application of Osteocyte-Related Biomarkers, Fibroblast Growth Factor-23, Sclerostin, and Dickkopf-1 in Predicting Osteoporosis and Fractures.
    Ramli FF; Chin KY
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32155909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
    Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
    J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis.
    Ueland T; Stilgren L; Bollerslev J
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1).
    Dincel AS; Jørgensen NR;
    Calcif Tissue Int; 2023 Feb; 112(2):243-257. PubMed ID: 36165920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How much do we know about the role of osteocytes in different phases of fracture healing? A systematic review.
    Choy MHV; Wong RMY; Chow SKH; Li MC; Chim YN; Li TK; Ho WT; Cheng JCY; Cheung WH
    J Orthop Translat; 2020 Mar; 21():111-121. PubMed ID: 32309136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating osteocyte-related biomarkers (vitamin D, sclerostin, dickkopf-1), hepcidin, and oxidative stress markers in early breast cancer: Their impact in disease progression and outcome.
    El-Mahdy RI; Zakhary MM; Maximous DW; Mokhtar AA; El Dosoky MI
    J Steroid Biochem Mol Biol; 2020 Nov; 204():105773. PubMed ID: 33065276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocyte recruitment declines as the osteon fills in: interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck.
    Power J; Doube M; van Bezooijen RL; Loveridge N; Reeve J
    Bone; 2012 May; 50(5):1107-14. PubMed ID: 22353552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocytes.
    Rupp M; Merboth F; Daghma DE; Biehl C; El Khassawna T; Heiß C
    Z Orthop Unfall; 2019 Apr; 157(2):154-163. PubMed ID: 30366349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocyte deficiency in hip fractures.
    Delgado-Calle J; Arozamena J; García-Renedo R; García-Ibarbia C; Pascual-Carra MA; González-Macías J; Riancho JA
    Calcif Tissue Int; 2011 Oct; 89(4):327-34. PubMed ID: 21874545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition.
    Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bromodomain Inhibitor
    Siegenthaler B; Ghayor C; Gjoksi-Cosandey B; Ruangsawasdi N; Weber FE
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
    Kalaitzoglou E; Popescu I; Bunn RC; Fowlkes JL; Thrailkill KM
    Curr Osteoporos Rep; 2016 Dec; 14(6):310-319. PubMed ID: 27704393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
    Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
    J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Close negative correlation of local and circulating Dickkopf-1 and Sclerostin levels during human fracture healing.
    Starlinger J; Santol J; Kaiser G; Sarahrudi K
    Sci Rep; 2024 Mar; 14(1):6524. PubMed ID: 38499638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis.
    Gatti D; Viapiana O; Idolazzi L; Fracassi E; Ionescu C; Dartizio C; Troplini S; Kunnathully V; Adami S; Rossini M
    Bone; 2014 Oct; 67():189-92. PubMed ID: 25003812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-sclerostin - is there an indication?
    Larsson S
    Injury; 2016 Jan; 47 Suppl 1():S31-5. PubMed ID: 26768288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
    Rossini M; Gatti D; Adami S
    Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
    Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
    Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.